Fresenius reported 8.32B in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Akzo Nobel AKZA:NA 2.18B 57M
Alcon AG ALC:SW 2.08B 201M
AstraZeneca AZN:LN 11.54B 4.45B
BASF BAS:GR 17.85B 410M
Bayer BAYN:GR 9.25B 3.88B
Davita Healthcare Partners DVA:US $ 2463.44M 37.41M
DSM DSM:NA € 2004M 235M
E.ON EOAN:GR 13.84B 1.48B
Fresenius FRE:GR 8.32B 91M
Fresenius Medical Care FMS:US 3.94B 40.05M
Fresenius Medical Care FME:GR 3.94B 40.05M
Getinge GETIB:SS 5.21B 170M
Givaudan GIVN:VX 2.76B 123M
GlaxoSmithKline GSK:LN 7.14B 722M
GN Store Nord GN:DC 3.22B 22M
Hikma Pharmaceutical HIK:LN 873M 27M
Lonza Group LONN:SW 2.22B 1.07B
Merck MRK:GR 3.93B 105M
Novartis NOVN:VX 10.13B 319M
Philips PHIA:NA € 3798M 347M
RWE RWE:GR 2.81B 323M
William Demant Holding WDH:DC 7.37B 399M